Highly protective antimalarial antibodies via precision library generation and yeast display screening
<jats:p>The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturatio...
Main Authors: | Banach, Bailey B, Tripathi, Prabhanshu, Da Silva Pereira, Lais, Gorman, Jason, Nguyen, Thuy Duong, Dillon, Marlon, Fahad, Ahmed S, Kiyuka, Patience K, Madan, Bharat, Wolfe, Jacy R, Bonilla, Brian, Flynn, Barbara, Francica, Joseph R, Hurlburt, Nicholas K, Kisalu, Neville K, Liu, Tracy, Ou, Li, Rawi, Reda, Schön, Arne, Shen, Chen-Hsiang, Teng, I-Ting, Zhang, Baoshan, Pancera, Marie, Idris, Azza H, Seder, Robert A, Kwong, Peter D, DeKosky, Brandon J |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
Rockefeller University Press
2022
|
Online Access: | https://hdl.handle.net/1721.1/145918 |
Similar Items
-
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site
by: Banach, Bailey B, et al.
Published: (2025) -
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: DeKosky, Brandon J.
Published: (2022) -
Expanding the landscape of antibody discovery
by: Johnson, Shelbe, et al.
Published: (2025) -
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
by: Kisalu, Neville K, et al.
Published: (2020) -
Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
by: Madan, Bharat, et al.
Published: (2022)